Abstract

1500P - Patients with metastatic non-small cell lung cancer without molecular alterations or PD-L1 expression in Germany: Treatment and first outcome from the prospective German Registry Platform CRISP (AIO-TRK-0315)

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
1552P - Patients with metastatic non-small cell lung cancer and targetable molecular alterations in Germany. Treatment and first outcome data from the prospective German Registry Platform CRISP (AIO-TRK-0315)
F Griesinger ... M Thomas
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. 30
F Griesinger, et. al.F Griesinger ... M Thomas
01 Oct 2019
1519P - Patients with metastatic non-small cell lung cancer and PD-L1 expression in Germany: Treatment and first outcome from the prospective German Registry Platform CRISP (AIO-TRK-0315)
M Sebastian ... M Thomas
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. 30
M Sebastian, et. al.M Sebastian ... M Thomas
01 Oct 2019
1275P - Safety and clinical activity of subcutaneously (SC) administered anti-PD-1 antibody PF-06801591 in phase I dose-expansion cohorts of locally advanced or metastatic non-small cell lung cancer (NSCLC) and urothelial carcinoma (UC)
B.C Cho ... M.L Johnson
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. 30
B.C Cho, et. al.B.C Cho ... M.L Johnson
01 Oct 2019
1590TiP - Safety, tolerability and activity of autologous T-cells with enhanced T-cell receptors specific to NY ESO 1/LAGE 1a (GSK3377794) alone, or in combination with pembrolizumab, in advanced non-small cell lung cancer: A phase Ib/IIa randomised pilot study
...
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. 30
, et. al. ...
01 Oct 2019
View more papers

More From: Annals of oncology : official journal of the European Society for Medical Oncology

Paper Title
Journal
Date
Author
Neratinib and ado-trastuzumab emtansine for pretreated and untreated human epidermal growth factor receptor 2 (HER2)-positive breast cancer brain metastases: Translational Breast Cancer Research Consortium trial 022
R.A Freedman ... N.U Lin
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. -
R.A Freedman, et. al.R.A Freedman ... N.U Lin
06 Jul 2024
Primary tumor resection for asymptomatic colorectal cancer with unresectable metastasis: the end of the dilemma
Sebastiano Biondo ... Esther Kreisler
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. -
Sebastiano Biondo, et. al.Sebastiano Biondo ... Esther Kreisler
03 Jul 2024
Challenging immune exhaustion in early recurrent triple-negative breast cancer: pitfalls and hopes
P Tarantino ... S M Tolaney
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. 35
P Tarantino, et. al.P Tarantino ... S M Tolaney
01 Jul 2024
Elevating Cancer on the Global Health Agenda: Towards the 4th High-Level Meeting on NCDs 2025
Raffaella Casolino ... Andrè Ilbawi
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. -
Raffaella Casolino, et. al.Raffaella Casolino ... Andrè Ilbawi
01 Jul 2024
View more papers